1. Home
  2. CVRX vs TMCI Comparison

CVRX vs TMCI Comparison

Compare CVRX & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$7.31

Market Cap

201.0M

Sector

Health Care

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.42

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVRX
TMCI
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.0M
174.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CVRX
TMCI
Price
$7.31
$2.42
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$13.17
$4.21
AVG Volume (30 Days)
371.4K
707.1K
Earning Date
02-04-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,969,000.00
$218,879,000.00
Revenue This Year
$11.91
$3.30
Revenue Next Year
$15.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.44
7.90
52 Week Low
$4.30
$2.36
52 Week High
$17.78
$10.79

Technical Indicators

Market Signals
Indicator
CVRX
TMCI
Relative Strength Index (RSI) 50.09 35.40
Support Level $6.96 $2.56
Resistance Level $6.09 $2.75
Average True Range (ATR) 0.81 0.17
MACD 0.17 0.00
Stochastic Oscillator 60.17 0.76

Price Performance

Historical Comparison
CVRX
TMCI

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: